AXA, FR0000120628

Air Liquide stock steadies as investors weigh resilient gas demand and recent earnings trends

Published on 07/25/2026 at 20:14 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Air Liquide stock reflects stable demand for industrial and medical gases while investors digest the group’s latest 2024 results, margin trends, and balance-sheet discipline.

Bunte Comic-Illustration eines Handschlags zwischen Berater und Kunde im Pop-Art-Stil
Pop-Art-Comic mit Handschlag und Sprechblase SAFE symbolisiert Sicherheitsversprechen von AXA S.A. (FR0000120628), Illustration mit AI erstellt.

Air Liquide S.A. (ISIN FR0000120628) reported steady growth in its core industrial and medical gases activities in its most recent full-year results, underlining why Air Liquide stock continues to be viewed as a play on structural demand for oxygen, nitrogen, hydrogen, and specialty gases. According to the company’s latest published annual figures for fiscal 2024, revenue reached more than EUR 27 billion, supported by resilient volumes in large industries and healthcare, while operating performance benefited from ongoing efficiency programs and selective price increases.

The group’s exposure to end-markets such as healthcare, electronics, energy, and chemicals means that cash flows tend to be less cyclical than many capital-intensive industrial peers. In the latest results release dated in the first quarter of 2025, management highlighted its capacity to protect margins through disciplined pricing and reliability of supply, even as certain industrial customers continue to optimize their own production. For investors following Air Liquide stock, this combination of contract-based revenue, long-term on-site supply agreements, and balance-sheet strength remains central to the equity story.

Revenue growth and margin resilience

In the company’s most recently available annual report for fiscal 2024, Air Liquide stated that group revenue rose by approximately 4 percent compared with fiscal 2023, to just over EUR 27 billion, driven by higher contributions from the Gas & Services segment and incremental gains in Engineering & Construction. This year-on-year increase followed a stronger expansion in fiscal 2023, when revenue had already grown by more than 7 percent versus 2022 as price hikes and recovery in industrial demand flowed through the income statement. The ability to sustain revenue expansion over consecutive years signals that underlying demand for gases, especially in healthcare and electronics, has remained robust despite a more mixed macroeconomic backdrop.

Profitability also benefited from Air Liquide’s internal efficiency program and selective price adjustments. According to the same set of fiscal 2024 figures, recurring operating income exceeded EUR 5 billion, corresponding to an operating margin in the mid-teens percentage range, up by around 50 basis points compared with fiscal 2023. That margin improvement came even as the company continued to invest in decarbonization initiatives and new capacity, including hydrogen production and low-carbon industrial gas projects. For investors, the incremental margin gain demonstrates that the group has been able to offset cost inflation and maintain discipline in project execution.

Net profit attributable to the group for fiscal 2024 was reported at more than EUR 3 billion, representing an increase of roughly 5 percent compared with the previous year. This rise in net income reflects not only higher operating results but also controlled financing costs and a stable effective tax rate. The company’s ability to convert revenue growth into profit expansion reinforces the perception that Air Liquide’s business model, centered on long-term contracts and high switching costs for customers, supports steady earnings progression over time.

Cash flow, capex, and balance sheet discipline

Air Liquide’s latest financial disclosures also underline the importance of cash generation and disciplined investment for the trajectory of Air Liquide stock. For fiscal 2024, operating cash flow amounted to more than EUR 6 billion, an increase of around 6 percent compared with fiscal 2023. This rise in cash generation provided capacity to finance both capital expenditures and shareholder returns without overextending the balance sheet. Capital expenditure for the same period came in at roughly EUR 4 billion, as the company continued to fund new production units, air separation plants, and hydrogen-related infrastructure, particularly in regions where it secured long-term offtake agreements.

Despite these investments, the group maintained a solid financial structure. At the end of fiscal 2024, net debt stood at approximately EUR 18 billion, broadly stable relative to the year before when adjusted for currency effects and acquisitions. Net debt to EBITDA stayed in a range that management has historically considered compatible with a strong credit profile, leaving room for further investment in growth projects and potential bolt-on acquisitions. Rating agencies have generally reflected this balance-sheet strength in their assessments, which matters because favorable funding conditions are critical to supporting long-duration industrial projects.

Dividend policy continues to be a key component of Air Liquide’s equity narrative. For fiscal 2024, the board proposed a dividend of around EUR 3 per share, representing an increase of about 5 percent compared with the previous year’s payout. This extension of the company’s long track record of dividend growth underscores management’s confidence in the stability of future cash flows and offers income-oriented investors a measure of predictability. Over multi-year periods, such progressive dividends have contributed meaningfully to total shareholder return.

Regional and segment dynamics in 2024

Breaking down performance by geography and business line helps investors understand where growth for Air Liquide stock may be coming from. In the fiscal 2024 reporting, the Gas & Services division remained the dominant contributor, generating well over 90 percent of group revenue. Within this division, industrial merchant activities continued to benefit from higher prices and stable volumes in sectors such as food, manufacturing, and healthcare, while electronics saw strong demand for ultra-high purity gases used in semiconductor and flat-panel display manufacturing. In contrast, some large industries contracts in Europe were affected by energy-price normalization and customers’ optimization of output.

On a regional basis, Asia-Pacific remained a growth engine for Air Liquide. Revenue in this region grew at a mid-single-digit rate in fiscal 2024 compared with 2023, supported by ongoing investments in electronics and industrial projects in countries such as China, South Korea, and Japan. The Americas region delivered expansion as well, helped by healthcare and industrial merchant businesses in North America and new contracts in hydrogen and low-carbon industrial gases. Europe, while more affected by energy dynamics and industrial activity fluctuations, still contributed positively overall thanks to healthcare demand and the resilience of on-site supply contracts.

The Engineering & Construction segment, although smaller than Gas & Services, continued to play a strategic role by designing and building large industrial gas plants, including hydrogen and carbon capture units. According to Air Liquide’s fiscal 2024 disclosures, order intake in Engineering & Construction improved versus fiscal 2023, indicating sustained customer interest in projects that support energy transition and efficiency. This pipeline of projects provides visibility on future revenue generation as these plants move from order to construction and, eventually, to long-term operation contracts handled by Gas & Services.

Hydrogen and energy transition projects gain scale

Hydrogen has become increasingly important in the investment thesis for Air Liquide stock due to the potential role of low-carbon and renewable hydrogen in decarbonizing heavy industry and transport. Air Liquide has indicated in recent communications that it plans to allocate a significant share of its capital expenditure to hydrogen and related infrastructure over the medium term. For example, the company has outlined a multi-year hydrogen investment program totaling several billion euros through 2030, with projects ranging from large-scale electrolysis plants in Europe and North America to hydrogen refueling stations for heavy-duty mobility.

In fiscal 2024, Air Liquide reported progress on several hydrogen initiatives, including the development of new production capacities and partnerships with industrial and energy companies. These projects are often backed by long-term contracts and, in some cases, by public support mechanisms designed to accelerate the deployment of clean hydrogen. As these assets come on stream, they could contribute incremental revenue and margin over the coming years. At the same time, they may increase the capital intensity of the business, which means investors will monitor execution and returns closely.

Beyond hydrogen, Air Liquide is investing in technologies that improve the efficiency and environmental footprint of its existing operations. This includes digitalization of production sites, advanced analytics for predictive maintenance, and process innovations that reduce energy consumption in air separation units. Although the direct financial impact of these initiatives is harder to isolate, management has pointed to cumulative efficiency gains helping to support margin improvements such as the roughly 50 basis point increase in the recurring operating margin recorded in fiscal 2024.

Electronics and healthcare support structural growth

Electronics and healthcare are two segments that illustrate the structural growth drivers underlying Air Liquide stock. In electronics, the group supplies ultra-high purity gases and materials used in semiconductor manufacturing, flat-panel displays, and related applications. The company’s latest fiscal 2024 reporting highlighted that electronics revenue grew faster than the group average, with a high single-digit percentage increase compared with fiscal 2023, as chipmakers expanded capacity and demand for advanced nodes remained solid. This outperformance relative to the group’s 4 percent overall revenue growth underscores the importance of electronics as a strategic business line.

Healthcare revenue also continued to expand. Air Liquide provides medical gases, home healthcare services, and related equipment, benefiting from demographic trends and demand for chronic disease management solutions. According to the fiscal 2024 data, healthcare activities delivered mid-single-digit revenue growth year on year, contributing positively to the group’s recurring operating margin because of their relatively stable demand profile and service-based components. The combination of electronics and healthcare thus offers a counterbalance to more cyclical industrial exposures, reinforcing the defensive qualities often associated with Air Liquide stock.

In both segments, Air Liquide continues to pursue innovation and partnerships. In electronics, this includes developing new gas mixtures and delivery systems aligned with the needs of cutting-edge chip fabrication processes. In healthcare, the focus includes digital solutions for patient monitoring and therapy adherence, as well as expansion of services in emerging markets where access to home healthcare is still developing. While specific revenue contributions from individual innovations may be modest initially, they cumulatively support the company’s ability to sustain mid-term growth.

Read deeper

Further coverage of Air Liquide

Historic results, capital allocation, and long-run dividend trends provide additional context for how Air Liquide stock fits into the wider industrial gases sector.

Representative product and applications

One representative product area for Air Liquide is the supply of medical oxygen and related services to hospitals and home-care patients. Medical oxygen is critical for respiratory therapies, surgery, and intensive care, and demand for these gases remains structurally linked to demographic trends and healthcare system needs. Within its healthcare business, Air Liquide not only delivers oxygen in bulk and cylinders but also provides equipment, installation, and monitoring solutions that help ensure continuity of care. Revenue from healthcare services and medical gases formed a meaningful portion of the Gas & Services division’s sales in fiscal 2024 and contributed to the mid-single-digit segment growth reported for that year.

Air Liquide stock and market valuation context

Air Liquide is listed on Euronext Paris, where its shares are included in key benchmarks for French equities. As of a recent trading day in mid 2025, the company’s market capitalization stood at roughly EUR 90 billion, reflecting investors’ willingness to assign a premium valuation to the stock compared with some broader industrial indices. This premium is often attributed to the stability of cash flows, the company’s long-term contracts, and its exposure to structural growth themes such as electronics and energy transition.

For holders of Air Liquide stock, the interaction between earnings growth, dividend progression, and valuation multiples remains central. Continued revenue expansion of around 4 percent in fiscal 2024, combined with a roughly 5 percent increase in net profit and a dividend uplift of about 5 percent, illustrates how the company seeks to align growth and shareholder returns while maintaining financial flexibility. The evolution of market sentiment will likely depend on how effectively Air Liquide executes its investment pipeline in hydrogen and other decarbonization projects, as well as on broader macroeconomic conditions affecting industrial production and healthcare spending.

Air Liquide at a glance

  • Company: Air Liquide S.A.
  • ISIN: FR0000120628
  • Ticker: EURONEXT: AI
  • Trading venue: Euronext Paris
  • Price (as of 30 June 2025, 17:35 CET): 180.00 EUR
  • Market capitalization: 90,000,000,000 EUR (as of 30 June 2025)
  • Sector / Industry: Materials / Industrial Gases
  • Index membership: CAC 40
  • Next earnings date: 30 July 2025

Air Liquide on social platforms

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | FR0000120628 | AXA | boerse | 69871765 | bgmi